Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase
Abstract A novel series of hybrid analogues of monastrol-1,3,5-triazine were designed and developed via one-pot synthesis using Bi(NO3)3 as a catalyst. Entire compounds were evaluated for their anticancer activity against HeLa (cervical cancer), MCF-7 (breast cancer), HL-60 (Human promyelocytic leuk...
Guardado en:
Autores principales: | Jitendra Kumar Srivastava, Girinath G. Pillai, Hans Raj Bhat, Amita Verma, Udaya Pratap Singh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a3f39bb0c73b423ba93335c416a0a7bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Enantioselective three-component aminomethylation of α-diazo ketones with alcohols and 1,3,5-triazines
por: Jiuwei Che, et al.
Publicado: (2020) -
Docking-Guided 3D-QSAR Studies of 4-Aminoquinoline-1,3,5-triazines as Inhibitors for <i>Plasmodium falciparum</i> Dihydrofolate Reductase
por: Radite Yogaswara, et al.
Publicado: (2020) -
A NEW METHOD FOR ONE-POT SYNTHESIS OF ARYLOXYPHENOXYPROPIONATE HERBICIDES USING 2,4,6-TRICHLORO-1,3,5-TRIAZINE AND (n-BU)4NI AS A HOMOGENEOUS CATALYST
por: KALHOR,MEHDI, et al.
Publicado: (2011) -
Acta No. 135
por: Banco Central de Chile
Publicado: (2019) -
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
por: Patrice Dubreuil, et al.
Publicado: (2009)